Reengineering the pharmaceutical industry by crash-testing molecules.
about
Virtual target screening: validation using kinase inhibitors.In silico pharmacology for drug discovery: applications to targets and beyondStructure Activity Relationships (SARs) Using a Structurally Diverse Drug Database: Validating Success of Predictor Tools.In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim®.
P2860
Reengineering the pharmaceutical industry by crash-testing molecules.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Reengineering the pharmaceutical industry by crash-testing molecules.
@ast
Reengineering the pharmaceutical industry by crash-testing molecules.
@en
type
label
Reengineering the pharmaceutical industry by crash-testing molecules.
@ast
Reengineering the pharmaceutical industry by crash-testing molecules.
@en
prefLabel
Reengineering the pharmaceutical industry by crash-testing molecules.
@ast
Reengineering the pharmaceutical industry by crash-testing molecules.
@en
P1433
P1476
Reengineering the pharmaceutical industry by crash-testing molecules.
@en
P304
P356
10.1016/S1359-6446(05)03557-9
P577
2005-09-01T00:00:00Z